Journey Medical (DERM) Competitors

Journey Medical (NASDAQ:DERM) and Xencor (NASDAQ:XNCR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Which has better earnings & valuation, DERM or XNCR?

Journey Medical has higher earnings, but lower revenue than Xencor. Journey Medical is trading at a lower price-to-earnings ratio than Xencor, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Journey Medical	$56.13M	2.83	-$3.85M	-$0.39	-17.64
Xencor	$127.23M	4.55	-$126.09M	-$3.06	-2.66

Do analysts recommend DERM or XNCR?

Journey Medical presently has a consensus price target of $9.88, suggesting a potential upside of 43.53%. Xencor has a consensus price target of $29.50, suggesting a potential upside of 262.41%. Given Xencor's higher probable upside, analysts clearly believe Xencor is more favorable than Journey Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Journey Medical	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Xencor	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89

Which has more risk and volatility, DERM or XNCR?

Journey Medical has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Xencor has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

Does the MarketBeat Community favor DERM or XNCR?

Xencor received 502 more outperform votes than Journey Medical when rated by MarketBeat users. However, 87.50% of users gave Journey Medical an outperform vote while only 73.13% of users gave Xencor an outperform vote.

Company	Underperform	Outperform
Journey Medical	Outperform Votes 7 87.50%	Underperform Votes 1 12.50%
Xencor	Outperform Votes 509 73.13%	Underperform Votes 187 26.87%

Do insiders & institutionals believe in DERM or XNCR?

7.3% of Journey Medical shares are held by institutional investors. 15.0% of Journey Medical shares are held by insiders. Comparatively, 4.8% of Xencor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is DERM or XNCR more profitable?

Journey Medical has a net margin of -31.74% compared to Xencor's net margin of -232.77%. Xencor's return on equity of -30.92% beat Journey Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Journey Medical	-31.74%	-132.10%	-26.90%
Xencor	-232.77%	-30.92%	-21.74%

Does the media prefer DERM or XNCR?

In the previous week, Journey Medical had 7 more articles in the media than Xencor. MarketBeat recorded 15 mentions for Journey Medical and 8 mentions for Xencor. Xencor's average media sentiment score of 0.31 beat Journey Medical's score of 0.22 indicating that Xencor is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Journey Medical	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Xencor	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Xencor beats Journey Medical on 10 of the 18 factors compared between the two stocks.